Vasoactive pharmacological management according to SCAI class in patients with acute myocardial infarction and cardiogenic shock
Sign Up to like & getrecommendations! Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0272279
Abstract: Background Vasoactive treatment is a cornerstone in treating hypoperfusion in cardiogenic shock following acute myocardial infarction (AMICS). The purpose was to compare the achievement of treatment targets and outcome in relation to vasoactive strategy in… read more here.
Keywords: scai class; class; mortality; treatment targets ... See more keywords